company background image
RPGL

RPG Life SciencesNSEI:RPGLIFE Stock Report

Market Cap

₹10.3b

7D

-0.6%

1Y

70.6%

Updated

26 Nov, 2021

Data

Company Financials
RPGLIFE fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance6/6
Financial Health6/6
Dividends3/6

RPGLIFE Stock Overview

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally.

Price History & Performance

Summary of all time highs, changes and price drops for RPG Life Sciences
Historical stock prices
Current Share Price₹619.85
52 Week High₹752.45
52 Week Low₹341.90
Beta0.77
1 Month Change-8.60%
3 Month Change23.61%
1 Year Change70.64%
3 Year Change164.89%
5 Year Change28.92%
Change since IPO1,280.51%

Recent News & Updates

Aug 24
Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now

Shareholders May Be More Conservative With RPG Life Sciences Limited's (NSE:RPGLIFE) CEO Compensation For Now

Performance at RPG Life Sciences Limited ( NSE:RPGLIFE ) has been reasonably good and CEO Yugal Kishor Sikri has done a...

Jun 14
A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

A Look At The Intrinsic Value Of RPG Life Sciences Limited (NSE:RPGLIFE)

How far off is RPG Life Sciences Limited ( NSE:RPGLIFE ) from its intrinsic value? Using the most recent financial...

Shareholder Returns

RPGLIFEIN PharmaceuticalsIN Market
7D-0.6%0.7%-0.6%
1Y70.6%16.7%47.7%

Return vs Industry: RPGLIFE exceeded the Indian Pharmaceuticals industry which returned 16.5% over the past year.

Return vs Market: RPGLIFE exceeded the Indian Market which returned 48% over the past year.

Price Volatility

Is RPGLIFE's price volatile compared to industry and market?
RPGLIFE volatility
RPGLIFE Average Weekly Movement8.4%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement6.0%
10% most volatile stocks in IN Market9.0%
10% least volatile stocks in IN Market3.8%

Stable Share Price: RPGLIFE is more volatile than 75% of Indian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: RPGLIFE's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of Indian stocks.

About the Company

FoundedEmployeesCEOWebsite
19681,107Yugal Kishor Sikrihttps://www.rpglifesciences.com

RPG Life Sciences Limited, an integrated pharmaceutical company, develops, manufactures, and markets branded formulations, generic, and synthetic active pharmaceutical ingredients (APIs) in India and internationally. The company offers synthetic APIs in various therapeutic categories, including immunosuppressants, anti-psychotic, anti-anginal, anthelmentics, anti-convulsant, anti-spasmodic, etc. It also provides generics primarily in the area of immunosuppressant therapy; and finished dosage formulations for various therapies, such as nephrology, oncology, urology, respiratory, vitamins and minerals, gastro intestinal, pain management, cardio-vascular, etc. primarily under the Lomotil, Lomofen+, Naprosyn, Azoran, Aldactone, and Serenace brand names. The company was formerly known as RPG Pharmaceuticals Limited and changed its name to RPG Life Sciences Limited in February 2008.

RPG Life Sciences Fundamentals Summary

How do RPG Life Sciences's earnings and revenue compare to its market cap?
RPGLIFE fundamental statistics
Market Cap₹10.26b
Earnings (TTM)₹491.20m
Revenue (TTM)₹4.21b

20.9x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RPGLIFE income statement (TTM)
Revenue₹4.21b
Cost of Revenue₹1.45b
Gross Profit₹2.76b
Expenses₹2.27b
Earnings₹491.20m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)29.70
Gross Margin65.63%
Net Profit Margin11.66%
Debt/Equity Ratio0.06%

How did RPGLIFE perform over the long term?

See historical performance and comparison

Dividends

1.2%

Current Dividend Yield

24%

Payout Ratio

Valuation

Is RPG Life Sciences undervalued compared to its fair value and its price relative to the market?

34.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: RPGLIFE (₹620.2) is trading below our estimate of fair value (₹939.2)

Significantly Below Fair Value: RPGLIFE is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: RPGLIFE is good value based on its PE Ratio (20.9x) compared to the Indian Pharmaceuticals industry average (21.2x).

PE vs Market: RPGLIFE is poor value based on its PE Ratio (20.9x) compared to the Indian market (19.1x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate RPGLIFE's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: RPGLIFE is overvalued based on its PB Ratio (4.4x) compared to the IN Pharmaceuticals industry average (2.7x).


Future Growth

How is RPG Life Sciences forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

20.5%

Forecasted Pharmaceuticals & Biotech industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as RPG Life Sciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Past Performance

How has RPG Life Sciences performed over the past 5 years?

27.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: RPGLIFE has high quality earnings.

Growing Profit Margin: RPGLIFE's current net profit margins (11.7%) are higher than last year (8.4%).


Past Earnings Growth Analysis

Earnings Trend: RPGLIFE's earnings have grown significantly by 27% per year over the past 5 years.

Accelerating Growth: RPGLIFE's earnings growth over the past year (57.9%) exceeds its 5-year average (27% per year).

Earnings vs Industry: RPGLIFE earnings growth over the past year (57.9%) exceeded the Pharmaceuticals industry 31.7%.


Return on Equity

High ROE: RPGLIFE's Return on Equity (21%) is considered high.


Financial Health

How is RPG Life Sciences's financial position?


Financial Position Analysis

Short Term Liabilities: RPGLIFE's short term assets (₹2.0B) exceed its short term liabilities (₹844.6M).

Long Term Liabilities: RPGLIFE's short term assets (₹2.0B) exceed its long term liabilities (₹90.2M).


Debt to Equity History and Analysis

Debt Level: RPGLIFE has more cash than its total debt.

Reducing Debt: RPGLIFE's debt to equity ratio has reduced from 11.8% to 0.06% over the past 5 years.

Debt Coverage: RPGLIFE's debt is well covered by operating cash flow (53840%).

Interest Coverage: RPGLIFE's interest payments on its debt are well covered by EBIT (290.7x coverage).


Balance Sheet


Dividend

What is RPG Life Sciences's current dividend yield, its reliability and sustainability?

1.16%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: RPGLIFE's dividend (1.16%) is higher than the bottom 25% of dividend payers in the Indian market (0.35%).

High Dividend: RPGLIFE's dividend (1.16%) is low compared to the top 25% of dividend payers in the Indian market (1.46%).


Stability and Growth of Payments

Stable Dividend: RPGLIFE's dividend payments have been volatile in the past 10 years.

Growing Dividend: RPGLIFE's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its low payout ratio (24.2%), RPGLIFE's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.1yrs

Average management tenure


CEO

Yugal Kishor Sikri (64 yo)

3.08yrs

Tenure

₹39,147,000

Compensation

Mr. Yugal Kishor Choturam Sikri has been Managing Director and Director at RPG Life Sciences Limited since October 1, 2018 He served as an Independent & Non-Executive Director at RPG Life Sciences Limited...


CEO Compensation Analysis

Compensation vs Market: Yugal Kishor's total compensation ($USD524.70K) is above average for companies of similar size in the Indian market ($USD39.49K).

Compensation vs Earnings: Yugal Kishor's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: RPGLIFE's management team is considered experienced (3.1 years average tenure).


Board Members

Experienced Board: RPGLIFE's board of directors are considered experienced (7.1 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

RPG Life Sciences Limited's employee growth, exchange listings and data sources


Key Information

  • Name: RPG Life Sciences Limited
  • Ticker: RPGLIFE
  • Exchange: NSEI
  • Founded: 1968
  • Industry: Pharmaceuticals
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: ₹10.257b
  • Shares outstanding: 16.54m
  • Website: https://www.rpglifesciences.com

Number of Employees


Location

  • RPG Life Sciences Limited
  • RPG HOUSE
  • 463, Dr. Annie Besant Road
  • Mumbai
  • Maharashtra
  • 400030
  • India

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/26 12:07
End of Day Share Price2021/11/26 00:00
Earnings2021/09/30
Annual Earnings2021/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.